Hepatic glucagon receptor binding and glucose-lowering in vivo by peptidyl and non-peptidyl glucagon receptor antagonists.
Dallas-Yang Q, Shen X, Strowski M, Brady E, Saperstein R, Gibson RE, Szalkowski D, Qureshi SA, Candelore MR, Fenyk-Melody JE, Parmee ER, Zhang BB, Jiang G.
Dallas-Yang Q, et al. Among authors: fenyk melody je.
Eur J Pharmacol. 2004 Oct 6;501(1-3):225-34. doi: 10.1016/j.ejphar.2004.08.023.
Eur J Pharmacol. 2004.
PMID: 15464082